Cost-effectiveness of tofacitinib for the treatment of moderate to severe active ulcerative colitis in Greece.
Eur J Gastroenterol Hepatol. 2021 Mar 1;33(3):325-333. doi: 10.1097/MEG.0000000000001916.
Eur J Gastroenterol Hepatol. 2021.
PMID: 32976189